| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |